IE32619L - Preparations containing live organisms - Google Patents
Preparations containing live organismsInfo
- Publication number
- IE32619L IE32619L IE690057A IE5769A IE32619L IE 32619 L IE32619 L IE 32619L IE 690057 A IE690057 A IE 690057A IE 5769 A IE5769 A IE 5769A IE 32619 L IE32619 L IE 32619L
- Authority
- IE
- Ireland
- Prior art keywords
- aerosol
- dichlorodifluoromethane
- jan
- lyophilized
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Genetics & Genomics (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
1,247,219. Treating micro-organisms. SCIENCE UNION ET CIE SOC., FRANCAISE DE RECHERCHE MEDICALE. 17 Jan., 1969 [22 Jan., 1968; 22 April, 1968], No. 2779/69. Heading A2D. [Also in Divisions A5, C4 and C6] Lyophilized live bacteria or yeast in a pulverulent and substantially dry state are put up in the form of an aerosol package with dichlorodifluoromethane (or liquid nitrogen) propellant. Examples are directed to aerosol formulations of: (1) Staphylococcus aureus, (2) Bacillus subtilis, (3) Klebsiella pneumoniae, (4) Serratia marcescens, (5) Lactobacillus casei and (6) Saccharomyces cerevisiae lyophilized from sterile saline solution (in 1 to 4) or specified culture medium (in 5) and the dichlorodifluoromethane. The lyophilisation may be conducted in the containers used for the aerosol formulation. The aerosol package is preserved at temperatures between +25 and -30‹C until required for use.
[GB1247219A]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR136857 | 1968-01-22 | ||
FR148892A FR7414M (en) | 1968-04-22 | 1968-04-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE32619L true IE32619L (en) | 1969-07-22 |
IE32619B1 IE32619B1 (en) | 1973-10-03 |
Family
ID=26181742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE57/69A IE32619B1 (en) | 1968-01-22 | 1969-01-15 | Preparations containing live bacteria or yeast |
Country Status (10)
Country | Link |
---|---|
BE (1) | BE726775A (en) |
CA (1) | CA939261A (en) |
CH (1) | CH502438A (en) |
DE (1) | DE1902118C3 (en) |
DK (1) | DK124339B (en) |
GB (1) | GB1247219A (en) |
IE (1) | IE32619B1 (en) |
NL (1) | NL6901082A (en) |
NO (1) | NO125685B (en) |
OA (1) | OA03884A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9103905A (en) * | 1991-09-11 | 1993-03-23 | Geratec S A Biotecnologia Apli | PROCESS OF OBTAINING INOCULANT IN PO-WET FOR THE CULTURE OF VEGETABLES |
DE19512497C1 (en) * | 1995-04-04 | 1996-07-18 | Tuerk & Hillinger Gmbh | Through-flow electric heater |
JP2002306158A (en) * | 2000-05-15 | 2002-10-22 | Makoto Kumazaki | Composite culture material, method for producing composite culture material, precultured material, method for producing precultured material and method for producing microbial preparation |
-
1969
- 1969-01-10 BE BE726775D patent/BE726775A/xx unknown
- 1969-01-14 DK DK18669AA patent/DK124339B/en unknown
- 1969-01-15 IE IE57/69A patent/IE32619B1/en unknown
- 1969-01-16 DE DE1902118A patent/DE1902118C3/en not_active Expired
- 1969-01-17 NO NO0191/69A patent/NO125685B/no unknown
- 1969-01-17 GB GB2779/69A patent/GB1247219A/en not_active Expired
- 1969-01-20 CA CA40657A patent/CA939261A/en not_active Expired
- 1969-01-20 CH CH79769A patent/CH502438A/en not_active IP Right Cessation
- 1969-01-21 OA OA53481A patent/OA03884A/en unknown
- 1969-01-22 NL NL6901082A patent/NL6901082A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
OA03884A (en) | 1975-08-14 |
CH502438A (en) | 1971-01-31 |
DK124339B (en) | 1972-10-09 |
CA939261A (en) | 1974-01-01 |
IE32619B1 (en) | 1973-10-03 |
BE726775A (en) | 1969-07-10 |
NL6901082A (en) | 1969-07-24 |
NO125685B (en) | 1972-10-16 |
DE1902118C3 (en) | 1979-06-07 |
DE1902118B2 (en) | 1978-10-12 |
DE1902118A1 (en) | 1969-10-30 |
GB1247219A (en) | 1971-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2908614A (en) | Use of dextran in freeze-drying process | |
MXPA01011487A (en) | Conditioned cell culture medium compositions and methods of use. | |
CA2141803A1 (en) | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen | |
Tan et al. | Freeze-drying of fungi: influence of composition and glass transition temperature of the protectant | |
JPS6396107A (en) | Powdered cosmetic | |
US5834424A (en) | Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus | |
IE32619L (en) | Preparations containing live organisms | |
Suzuki et al. | Basis of chloramphenicol resistance in naturally isolated resistant staphylococci | |
Abdelaziz et al. | Microbial contamination of cosmetics and personal care items in Egypt—eye shadows, mascaras and face creams | |
WO2001037804A3 (en) | Preservation and formulation of bioactive materials | |
GB1040278A (en) | Bacterial compositions for the regeneration of the intestinal microflora | |
Umbreit et al. | A study of Thiobacillus thiooxidans with the electron microscope | |
EP0057349A3 (en) | Peptide antibiotic, component b, process for its preparation and its use in medicines | |
GB1488397A (en) | Preservation of boar semen | |
Reyes et al. | Heat resistance of Bacillus spores at various relative humidities | |
Nasir et al. | Microbiological contaminant isolation and detection in cosmetics sold in Iraq | |
Utsui et al. | Release of lipoteichoic acid from Staphylococcus aureus by treatment with cefmetazole and other β-lactam antibiotics | |
GB764718A (en) | Improvements in or relating to freeze-drying processes | |
Tessler | Reaction of the sterilant ethylene oxide on plastics | |
JPH0790250A (en) | Ice temperature improver and use thereof | |
ES8104402A1 (en) | Bacterial lysates | |
GB799644A (en) | Method for the dried storage of micro-organisms | |
SU413187A1 (en) | ||
Crevar et al. | A note on the stability of actinomycin D | |
GB1013571A (en) | Methods of preservation using pharmaceutical compositions comprising iodolium and bromolium cations |